Indefinite Delivery Contract 36E79726D0015
- Not listed
- This indefinite delivery contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Golden State Medical Supply, Inc. (GSMS), a for-profit pharmaceutical manufacturer and distributor, to provide an uninterrupted supply of Venlafaxine HCL tablets. The contract has a base period of one year from August 28, 2021 to August 27, 2022, with four one-year option periods, for a total ceiling value of $3,487,161.15. The contract items will be distributed through...
- Avkare LLC was awarded a single-award Indefinite Delivery Contract valued at $29.3 million by the Department of Veterans Affairs National Acquisition Center to supply venlafaxine hydrochloride extended-release capsules to multiple federal healthcare agencies including the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service. The contract, awarded on August 30, 2021, without set-aside designation, features a one-year base period from August 30, 2021,...
- Golden State Medical Supply, Inc. has been awarded a single-award Indefinite Delivery Contract by the Department of Veterans Affairs National Acquisition Center for the supply of Ambrisentan Tablets. The contract, effective April 1, 2026 through March 31, 2027, carries a ceiling value of $6.9 million and includes four one-year option periods, providing potential contract continuity through March 31, 2030. This civilian agency procurement is unrestricted and available to all responsible offerors,...
- The Department of Veterans Affairs National Acquisition Center awarded Golden State Medical Supply, Inc. a single-award indefinite delivery contract with a potential value of $2.29M for the delivery of clomipramine hydrochloride capsules. The contract was awarded on August 15, 2020 following a pre-solicitation notice and has a one-year base period of performance plus four one-year option periods extending to August 14, 2023. The contract aims to provide an uninterrupted supply of three...
- Golden State Medical Supply, Inc. was awarded a single-award Indefinite Delivery Contract (IDV) by the Department of Veterans Affairs National Acquisition Center for the supply of Prasugrel Tablets on March 28, 2025. The contract has a ceiling value of $2,445,241.70 and covers a one-year base ordering period from March 28, 2025, through March 27, 2026, with four optional one-year renewal periods extending through December 1, 2025. This unrestricted procurement serves multiple federal...
- Golden State Medical Supply, Inc. (UEI: GQLDJJ8AQNN5) was awarded a single-award Indefinite Delivery Contract by the Department of Veterans Affairs National Acquisition Center on February 20, 2025, to supply Norethindrone Acetate 5mg Tablets to multiple federal healthcare systems. The contract carries a ceiling value of $2,285,266.20 and covers a base period of performance from February 20, 2025, through February 19, 2026, with four one-year option periods extending through February 19, 2027....
- Golden State Medical Supply, Inc. (UEI: GQLDJJ8AQNN5) was awarded a multiple-award Federal Supply Schedule contract under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule by the Veterans Integrated Service Network 12, a civilian agency within the Department of Veterans Affairs. The contract, effective June 15, 2023, with an ultimate completion date of June 14, 2028, carries a ceiling value of $5.91 billion and was awarded without set-asides in an open competition. The contract is...
- Golden State Medical Supply, Inc. (UEI: GQLDJJ8AQNN5) was awarded a single-award Indefinite Delivery Contract by the Medical Supply Chain, a Defense-focused federal agency, to manufacture and distribute pharmaceutical products. The contract, with a ceiling value of $51.5 million and an ultimate completion date of September 16, 2025, was awarded on September 17, 2020, following a pre-solicitation posted on September 3, 2019. The originating solicitation sought a national requirements contract for...
- Golden State Medical Supply, Inc. was awarded a single-award indefinite delivery contract by the Department of Veterans Affairs National Acquisition Center to provide pharmaceutical products. The contract facilitates orders for prazusrel hydrochloride 5mg and 10mg tablets to VA hospitals and facilities through February 2025. With a potential value of $3,892,430.05, the contract leverages Golden State Medical Supply's distribution network to deliver specified medications on an as-needed basis...
- The Department of Veterans Affairs National Acquisition Center awarded a single-award Indefinite Delivery Contract to Golden State Medical Supply, Inc. to procure bupropion hydrochloride immediate release tablets. The contract has a one-year base period of performance beginning on November 14, 2019, plus four one-year option periods, for a potential total value of $4.285 million. Task orders will be placed against the contract through November 13, 2024 to facilitate delivery of the...
Golden State Medical Supply, Inc. has been awarded a single-award Indefinite Delivery Contract by the Department of Veterans Affairs National Acquisition Center for the supply of Venlafaxine HCL tablets with a ceiling value of $4.06 million. The contract period of performance runs from February 28, 2026 through February 27, 2027, with four one-year option periods available, potentially extending the contract through February 2031. This unrestricted procurement was awarded without set-asides and serves multiple federal healthcare agencies including the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service through the VA's Pharmaceutical Prime Vendor Programs. The contract leverages the commercial item format procedures under Federal Acquisition Regulation Part 12, reflecting the standardized nature of pharmaceutical procurement processes within federal healthcare systems. The solicitation identified annual requirements for five dosage strengths of Venlafaxine HCL tablets: 25 milligrams (5,854 bottles), 37.5 milligrams (13,163 bottles), 50 milligrams (4,259 bottles), 75 milligrams (52,995 bottles), and 100 milligrams (16,249 bottles), with each bottle containing 90 tablets, totaling 92,520 bottles annually. Venlafaxine HCL is an extended-release antidepressant medication commonly prescribed for treatment of major depressive disorder, generalized anxiety disorder, and panic disorder within federal healthcare systems. Golden State Medical Supply's award under this contract demonstrates the company's established capability as a critical pharmaceutical supplier to federal agencies and aligns with its extensive portfolio of single-award Indefinite Delivery Contracts covering multiple pharmaceutical products across the VA National Acquisition Center and Defense Logistics Agency networks.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 1/15/26 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
6505--Venlafaxine Tablets | 36E79725R0054 | Department of Veterans Affairs National Acquisition Center | Pre-Solicitation 1/3 | 8/1/25, 4:02 PM | |
6505--Venlafaxine Tablets | 36E79725R0054 | Department of Veterans Affairs National Acquisition Center | Award Notice 3/3 | 1/16/26, 11:51 AM | |
6505--Venlafaxine Tablets | 36E79725R0054 | Department of Veterans Affairs National Acquisition Center | Solicitation 2/3 | 8/12/25, 4:11 PM |